The need for companies to understand what physicians need in a new product or service and how a physician will integrate it into their practice is a straightforward proposition. However, not every physician is equipped to effectively collaborate with industry, and there currently is not a school be become a Chief Medical Officer or physician adviser.
During this interactive Q&A session, you’ll learn the ins and outs of how to become a medical advisor to companies at all levels of product development, including:
- Where to find opportunities and get started;
- How to seek and outline expectations around time and compensation;
- What resources and networking opportunities are available;
- Where you may encounter pitfalls and landmines and how to avoid them;
… and much more
Arlen Meyers, MD, MBA
Co-Founder, Society of Physician Entrepreneurs (SoPE)
Arlen Meyers, MD, MRA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health, serves as the Chief Medical Officer with BridgeHealth and Cliexa, and is President and CEO of the Society of Physician Entrepreneurs. He is an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape Reference: Otolaryngology-Head and Neck Surgery; is a faculty member at the University of Colorado Denver Graduate School and Direct the Program in Biomedical Entrepreneurship at the Jabs Center for Entrepreneurship at the University of Colorado Denver Business School, and
Dr. Meyers’ primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults with companies, governments, colleges and universities around the world seeking expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism — nationally and internationally, new product development, product design, and financing new ventures.
He is a former Harvard-Macy fellow; in 2010 he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. His publications this year include Building the Case for Biotechnology, Optical Detection of Cancer, and The Life Science Innovation Roadmap.
Thursday, December 14, 2017
– 7:45 am